AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN
Folia Medica Indonesiana · 2016
DOI: 10.20473/fmi.v51i3.2834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Medica Indonesiana, 2016. Verfasst von Oka Putrawan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Infection often occurs in children with malignant hematology and causes morbidity and mortality. Antibiotics should be given based on the results of culture and antibiotic susceptibility test. Ampicillin Sulbactam is a first-line drug in children with infection. The purpose of this study was to obtain an objective overview of Ampicillin Sulbactam resistance patterns of culture in patients hospitalized in pediatric Hemato-Oncology Ward, Dr Soetomo Hospital, Surabaya. This was a descriptive study. Data on culture and susceptibility test result to Ampicillin Sulbactam were taken from medical records of those patients between September 2012 - February 2013. There were 342 culture examinations in 88 patients (44 girls and 44 boys). Most of the children aged
Zitieren
APA
Putrawan, O., & Rejeki, I. P. S. (2016). AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN. Folia Medica Indonesiana. https://doi.org/10.20473/fmi.v51i3.2834
Vancouver
Putrawan O, Rejeki IPS. AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN. Folia Medica Indonesiana. 2016. doi:10.20473/fmi.v51i3.2834
BibTeX
@article{Putrawan2016,
author = {Putrawan, Oka and Rejeki, IGAA Putri Sri},
title = {AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN},
journal = {Folia Medica Indonesiana},
year = {2016},
doi = {10.20473/fmi.v51i3.2834}
}
EUVIMED